z-logo
open-access-imgOpen Access
Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports
Author(s) -
Réda Laamech,
Hamza Naciri-Bennani,
Diane Giovannini,
Johan Noble,
Bénédicte Janbon,
Paolo Malvezzi,
Thomas Jouvé,
Lionel Rostaing
Publication year - 2022
Publication title -
case reports in nephrology
Language(s) - English
Resource type - Journals
eISSN - 2090-6641
pISSN - 2090-665X
DOI - 10.1155/2022/9740225
Subject(s) - medicine , rituximab , transplantation , kidney transplantation , anti neutrophil cytoplasmic antibody , mizoribine , dialysis , plasmapheresis , vasculitis , gastroenterology , glomerulonephritis , immunology , kidney , antibody , urology , disease
Successful kidney transplantation (KTx) in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) has been reported with excellent patient and graft survival rates. The recurrence of AAV in transplant recipients is rare, and its mechanisms of action are not clearly known. The optimum time for KTx and the relevance of ANCA titer at the time of transplantation remain controversial. We report two cases of extremely rapid recurrent AAV after renal transplantation; both were still ANCA-positive at the time of transplantation, which led us to question the pathogenesis of ANCA antibodies in recurrence in a kidney allograft. Apheresis plus immunosuppressive therapies were ineffective in the first case and the patient became dialysis-dependent, whereas in the second case methylprednisone pulses plus rituximab infusions resulted in long-lasting remission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom